Back |
home / stock / ardx / ardx message board
Subject | By | Source | When |
---|---|---|---|
Let them drop the price, opportunity for others | Cosa | investorshub | 03/10/2023 9:53:19 PM |
Wow. What the heck MM doing there thing. | Outcast27 | investorshub | 03/10/2023 7:45:18 PM |
Yep. ATM for short traders. Think it will | Outcast27 | investorshub | 03/10/2023 2:48:52 PM |
Next catalyst: The company currently intends to submit | Cosa | investorshub | 03/08/2023 5:50:38 AM |
Right! nearly 50 million volume and only | Cosa | investorshub | 03/04/2023 12:55:29 AM |
Sort of makes me think it's not retail | ErnieBilco | investorshub | 03/03/2023 10:39:32 PM |
znewcar1: $ARDX 32% v53M c3.82 f198,575M H3.98 ML=RL2.82 gapNheld3.5 pushed to hod | znewcar1 | investorshangout | 03/03/2023 9:53:16 PM |
So quiet here on such a great day! | Cosa | investorshub | 03/03/2023 9:51:55 PM |
znewcar1: $ARDX hod3.84 ML=RL2.82 gapNgo tohod | znewcar1 | investorshangout | 03/03/2023 3:46:02 PM |
We should be hitting new 52 week high | Cosa | investorshub | 03/03/2023 6:08:51 AM |
CEO Mike Raab: | Cosa | investorshub | 03/03/2023 6:02:54 AM |
Crushed it! It's pretty impressive what | Cosa | investorshub | 03/03/2023 12:31:41 AM |
Yes, no way the questions will not be | Johnstonj27 | investorshub | 03/02/2023 7:21:41 PM |
Added some shares, averaging up a bit. | Cosa | investorshub | 02/27/2023 8:53:41 PM |
znewcar1: $ARDX 40% v129,6M C1.72 f187,459M H1.98 ML1.16 | znewcar1 | investorshangout | 11/18/2022 3:57:04 AM |
znewcar1: ARDX 38% v166,2M c1.70 f112,7M H1.79 3d bounce off the LL@.82 | znewcar1 | investorshangout | 12/03/2021 1:19:59 AM |
znewcar1: ARDX 32% v46,5M c1.14 f112M H1.31 S1.07 | znewcar1 | investorshangout | 11/30/2021 10:04:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...